SCHEMBL6819764

SCHEMBL6819764

O=C(NC(c1ccccc1)c1ccccc1)C(Cc1cc(F)cc(F)c1)NS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 10/20 0.58
MMP9 P14780 7/20 0.58
ADAMTS4 O75173 2/20 0.55
CTSS P25774 6/20 0.52
CTSK P43235 6/20 0.52
CTSL P07711 5/20 0.52
MMP13 P45452 3/20 0.50
MMP1 P03956 2/20 0.50
MMP3 P08254 2/20 0.50
ADAMTS5 Q9UNA0 1/20 0.50
MMP7 P09237 1/20 0.50
CTSB P07858 4/20 0.48
EEF2K O00418 1/20 0.46
MMP8 P22894 2/20 0.46
MMP12 P39900 1/20 0.46
MMP14 P50281 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL6818809 0.84 EEF2K (0.42) MMP9CTSSCTSLCTSBEEF2K
SCHEMBL6818217 0.82 ITGB3 (0.41) MMP2MMP9CTSLMMP13MMP1
SCHEMBL2454204 0.74 MMP2 (1.00) MMP2MMP9ADAMTS4CTSSCTSK
SCHEMBL32691785 0.74 MMP2 (1.00) MMP2MMP9ADAMTS4CTSSCTSK
SCHEMBL32691761 0.72 MMP2 (1.00) MMP2MMP9ADAMTS4MMP13MMP1
SCHEMBL6545297 0.72 MMP2 (1.00) MMP2MMP9ADAMTS4MMP13MMP1
SCHEMBL1920507 0.72 MMP2 (1.00) MMP2MMP9ADAMTS4MMP13MMP1
SCHEMBL7453817 0.70 ITGB1 (0.49) MMP2MMP9ADAMTS4CTSSCTSK
SCHEMBL6818852 0.70 ITGB3 (0.39) MMP2MMP9CTSLMMP13MMP1
SCHEMBL6818849 0.70 ITGB3 (0.39) MMP2MMP9CTSLMMP13MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004020402-A1 SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE DE NOVO PHARMACEUTICALS LIMITED (GB) 2004-03-11 WO claimed
WO-2004020402-A1 SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE DE NOVO PHARMACEUTICALS LIMITED (GB) 2004-03-11 WO disclosed